NCT06915766 2026-03-09
Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
Cogent Biosciences, Inc.
Available
Cogent Biosciences, Inc.
Autolus Limited
AbbVie
AbbVie
Phoenix Children's Hospital
Orca Biosystems, Inc.